We are looking for young people 2–17 years old to join a CD clinical trial to help us discover more about treating moderately to severely active ulcerative colitis. If you are looking for a potential new treatment option for moderately to severely active ulcerative colitis or moderate to severe IBD (including associated symptoms such as diarrhea with blood and pus, stomach pain, rectal pain, frequent fevers and/or anemia), consider one of our IBD research studies. All eligible participants will receive no-cost study-related care and study medication. Your young people 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the IBD research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrollment is limited, so please respond now.

We are looking for children 2 to 17 years of age to join a CD medical research study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or IBD (including associated symptoms such as chronic diarrhea, perianal fistula, constant need to poop, weight loss and/or eye pain), consider one of our research studies. All eligible participants will receive no-cost study-related care and study medication. Your children 2 to 17 years of age may be eligible to take part.

Your child may be eligible to take part in the research studies if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

See if your child qualifies.

Is your child currently experiencing moderate to severe ulcerative colitis flare-ups? Local Crohn’s disease research is testing a potential new medication to see if it may reduce bloody diarrhea, fistula, diarrhea, chronic fatigue, and/or eye pain associated with moderate to severe ulcerative colitis.
If you’re concerned about how moderate to severe ulcerative colitis affects your child’s life, find out more about the Crohn’s disease research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Find out if your child qualifies.

Is your child currently experiencing ulcerative colitis (UC) flare-ups? Local Crohn’s disease research study is testing a potential new medication to see if it may reduce diarrhea with blood, reduced appetite, bloody stool, frequent fevers, and/or anemia associated with ulcerative colitis (UC).
If you’re concerned about how ulcerative colitis (UC) affects your child’s life, find out more about the Crohn’s disease research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

Is your child currently experiencing moderate to severe Crohn’s disease flare-ups? Local Crohn’s disease trial is testing a potential new medication to see if it may reduce bloody diarrhea, diarrhea, rectal pain, malnutrition, and/or liver disease associated with moderate to severe Crohn’s disease.
If you’re concerned about how moderate to severe Crohn’s disease affects your child’s life, find out more about the Crohn’s disease trial.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

We are looking for young people aged 2 to 17 years to join a clinical research study to help us discover more about treating moderate to severe Crohn’s disease. If you are looking for a potential new treatment option for moderate to severe Crohn’s disease or IBD (including associated symptoms such as rectal bleeding, loss of appetite, rectal pain, chronic fatigue and/or eye pain), consider one of our ICD and UC clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your young people aged 2 to 17 years may be eligible to take part.

Your child may be eligible to take part in the ICD and UC clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing Crohn’s and ulcerative colitis flare-ups? Local UC clinical research study is testing a potential new medication to see if it may reduce diarrhea with blood and pus, mouth sores, abdominal pain, frequent fevers, and/or canker sores associated with Crohn’s and ulcerative colitis.
If you’re concerned about how Crohn’s and ulcerative colitis affects your child’s life, find out more about the UC clinical research study.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

See if your child qualifies.

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease clinical research is testing a potential new medication to see if it may reduce recurrent diarrhea, fatigue, bloody stool, weight loss, and/or canker sores associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease clinical research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Enrollment is limited so act quickly.

We are looking for children 2–17 years old to join a research study to help us discover more about treating UC. If you are looking for a potential new treatment option for UC or Crohn’s disease (CD) (including associated symptoms such as abdominal cramping, inflammation of the bowel or intestine, bloody stool, chronic fatigue and/or anemia), consider one of our clinical trials. All eligible participants will receive no-cost study-related care and study medication. Your children 2–17 years old may be eligible to take part.

Your child may be eligible to take part in the clinical trials if they:

• are 2‒17 years of age
• have been diagnosed with moderate to severe ulcerative colitis (UC) or Crohn’s disease (CD)
• have previously received treatment for UC or CD that has not worked.

Enrolling for a limited time.

Is your child currently experiencing Crohn’s flare-ups? Local Crohn’s disease research is testing a potential new medication to see if it may reduce diarrhea, loss of appetite, bloody stool, malnutrition, and/or anemia associated with Crohn’s.
If you’re concerned about how Crohn’s affects your child’s life, find out more about the Crohn’s disease research.

Your child may be eligible for one of the GI studies if they are 2‒17 years of age, have been diagnosed with moderate to severe UC or CD, and have previously received treatment for UC or CD that has not worked.

By joining the GI studies, your child may receive:

• Compensation for study-related time
• Reimbursement for study-related travel
• Study-related care from local doctors
• Study medication at no cost

Health insurance is not required to take part.

Is your child eligible?